ClinicalTrials.Veeva

Menu

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan (PKDL)

E

Epicentre

Status

Completed

Conditions

Post-kala-azar Dermal Leishmaniasis
Leishmaniasis, Visceral
Leishmaniasis

Study type

Observational

Funder types

Other

Identifiers

NCT05449717
PKDL/2184

Details and patient eligibility

About

This study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis.

Full description

This prospective, observational cohort study aims to describe the burden of Post-Kala-Azar Dermal Leishmaniasis and visceral leishmaniasis relapse in a cohort of patients discharged after successful treatment of primary visceral leishmaniasis from a hospital in Lankien, South Sudan.

Enrollment

52 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Primary visceral leishmaniasis patients who had a confirmed (serological and/or parasitological) diagnosis at admission, and who were discharged after successful treatment
  • Availability for follow up visits
  • Provision of informed consent, and in the case of minors 12 to 17 years of age, assent as well

Exclusion criteria

  • Unavailability for follow-up visits due to distance, inaccessibility, or refusal to participate
  • Diagnosis of prior primary visceral leishmaniasis done only on clinical basis

Trial contacts and locations

1

Loading...

Central trial contact

Rebecca M Coulborn, MPH; Etienne Gignoux, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems